Analyses / HUBS
SaaS CRM leader trading 57% below 52-week high; margin compression and elevated multiples amid AI competition create mixed signals.
A free account reveals HUBS's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Strong gross margins (84%) and 22% revenue growth support premium multiples. Dominant SMB-to-mid-market CRM; AI-powered features (agents, workflows) differentiate vs Salesforce. FCF conversion solid (19.9x P/FCF). Operating leverage inflection potential if opex controlled.
▼ Bear Case
Forward P/E 250x and EV/EBITDA 79x are stretched even for growth SaaS. Operating margin razor-thin (0.05%); 1.47% net margin shows profitability fragile. Down 57% from 52-week high signals momentum reversal. Insider selling 2.2:1 vs buying. Competitive AI risk from CRM giants (Salesforce, Microsoft).
Valuation
overvalued on traditional metrics; fair if growth + margins inflect — score 42/100
P/E 78x and forward P/E 250x are extreme for a 1.47% net margin business. EV/EBITDA 79x price-in flawless execution. P/S 3.7x is defensible for 84% gross margin + 22% growth, but operating leverage must materialize. Trade is pricing AI upside; downside execution risk uncompensated.
Technical Levels
Support · $195.00 (Stop-loss; 52-week 169 below that is structural floor.) · $210.00 (Recent consolidation anchor; entry zone low.) · $222.00 (Day low / near-term bounce floor.)
Resistance · $236.00 (Day high; immediate offer.) · $250.00 (Psychological / prior breakdown level.) · $300.00 (Bull case target; strong resistance if momentum returns.)
RSI: missing
Financial Health
Score 72/100. Strong liquidity (current 1.67, quick 1.60) indicates minimal solvency risk. Balance sheet is clean for a SaaS player. No dividend; all cash returns to growth. Tangible assets modest; value is in recurring revenue and brand.
Catalysts
| Next earnings report (Q4 / FY2024 guide) | Q1 2025 (typically late Feb / early March) | Highest near-term trigger. Guidance for margin improvement (operating leverage) could re-rate stock to 250–280. Miss on growth or margin guide risks 180–200 breakdown. |
| AI agent adoption metrics (land, expansion, churn) | Q1 2025 earnings call + subsequent analyst updates | Investors will scrutinize: (a) uptake of new AI workflows / agents, (b) impact on NRR (net revenue retention), (c) unit economics. Strong data supports 300+ bull case; weak adoption pushes bear case. |
| Competitive AI announcements (Salesforce, Microsoft) | Ongoing; potential major events in Q1–Q2 2025 | Each product parity move (e.g., Salesforce Agentforce feature releases, Microsoft Dynamics 365 Copilot bundling) pressures HUBS differentiation narrative and could trigger 5–10% corrections. |
| Insider transactions & stock buyback | Ongoing; quarterly | Current 2.2:1 insider sell/buy ratio is a yellow flag. If insiders resume buying, it's a confidence signal (+5% repricing). Buyback authorization can support technicals. |
| Macro / SMB spending sentiment | Continuous | SMB is cyclically sensitive; recession or layoff wave could crimp growth to <10%. Watch recession odds and small-business confidence indices for second-order HubSpot risk. |
Risk Flags
See HUBS's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock HUBS free →Recent News
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full HUBS analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
HUBS FAQ
Is HUBS a buy right now?
HubSpot Inc's current read is a growth-to-value transition setup with 62 confidence over a 6–12 months horizon. Valuation: overvalued on traditional metrics; fair if growth + margins inflect. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is HUBS overvalued?
overvalued on traditional metrics; fair if growth + margins inflect (valuation score 42/100). P/E 78x and forward P/E 250x are extreme for a 1.47% net margin business. EV/EBITDA 79x price-in flawless execution. P/S 3.7x is defensible for 84% gross margin + 22% growth, but operating leverage must materialize. Trade is pricing AI upside; downside execution risk uncompensated.
What are the risks of buying HUBS?
Forward P/E 250x and EV/EBITDA 79x are stretched even for growth SaaS. Operating margin razor-thin (0.05%); 1.47% net margin shows profitability fragile. Down 57% from 52-week high signals momentum reversal. Insider selling 2.2:1 vs buying. Competitive AI risk from CRM giants (Salesforce, Microsoft).